These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 31011260)
1. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease. Alfaro I; Masamunt MC; Planell N; López-García A; Castro J; Gallego M; Barastegui R; Giner A; Vara A; Salas A; Ricart E; Panés J; Ordás I World J Gastroenterol; 2019 Apr; 25(14):1764-1774. PubMed ID: 31011260 [TBL] [Abstract][Full Text] [Related]
2. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC. Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ; Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314 [TBL] [Abstract][Full Text] [Related]
3. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375 [TBL] [Abstract][Full Text] [Related]
4. Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies. Eder P; Stawczyk-Eder K; Korybalska K; Czepulis N; Luczak J; Lykowska-Szuber L; Krela-Kazmierczak I; Linke K; Witowski J World J Gastroenterol; 2017 Jan; 23(1):135-140. PubMed ID: 28104989 [TBL] [Abstract][Full Text] [Related]
5. Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn's Disease. Zittan E; Kabakchiev B; Milgrom R; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS J Crohns Colitis; 2016 May; 10(5):510-5. PubMed ID: 26783345 [TBL] [Abstract][Full Text] [Related]
6. Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission. Lin X; Qiu Y; Feng R; Chen B; He Y; Zeng Z; Zhang S; Chen M; Mao R Clin Transl Gastroenterol; 2020 Feb; 11(2):e00135. PubMed ID: 32463625 [TBL] [Abstract][Full Text] [Related]
7. Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX. Rivière P; D'Haens G; Peyrin-Biroulet L; Baert F; Lambrecht G; Pariente B; Bossuyt P; Buisson A; Oldenburg B; Vermeire S; Laharie D Am J Gastroenterol; 2021 Jan; 116(1):134-141. PubMed ID: 33177349 [TBL] [Abstract][Full Text] [Related]
8. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease. Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871 [TBL] [Abstract][Full Text] [Related]